{
    "id": 2792,
    "fullName": "ID4 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ID4 over exp indicates an over expression of the Id4 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3400,
        "geneSymbol": "ID4",
        "terms": [
            "ID4",
            "bHLHb27",
            "IDB4"
        ]
    },
    "variant": "over exp",
    "createDate": "12/19/2014",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1493,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of Id4 in glioma cells resulted in increased resistance to BCNU in culture (PMID: 21531766).",
            "molecularProfile": {
                "id": 2607,
                "profileName": "ID4 over exp"
            },
            "therapy": {
                "id": 1811,
                "therapyName": "Carmustine",
                "synonyms": null
            },
            "indication": {
                "id": 3070,
                "name": "malignant glioma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 1413,
                    "pubMedId": 21531766,
                    "title": "ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21531766"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 1494,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of Id4 in prostate cancer cells increased senescence and improved sensitivity to doxorubicin in culture (PMID: 24122992)",
            "molecularProfile": {
                "id": 2607,
                "profileName": "ID4 over exp"
            },
            "therapy": {
                "id": 1009,
                "therapyName": "Doxorubicin",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1414,
                    "pubMedId": 24122992,
                    "title": "Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24122992"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2607,
            "profileName": "ID4 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}